Skip to main content

Advertisement

Figure 2 | BMC Cancer

Figure 2

From: Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer

Figure 2

Study Design. 489 unselected patients were initially entered into this study. After tissue microarray construction, immunohistochemistry for VEGF ligands and receptors, 102 mismatch repair-deficient cases were excluded. Analysis of VEGF ligand/receptor ratio with clinico-pathological features and survival was performed on the remaining 387 mismatch repair-proficient cases.

Back to article page